Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards quantitative evaluation of wall shear stress from 4D flow imaging.
Levilly S, Castagna M, Idier J, Bonnefoy F, Le Touzé D, Moussaoui S, Paul-Gilloteaux P, Serfaty JM. Levilly S, et al. Among authors: castagna m. Magn Reson Imaging. 2020 Dec;74:232-243. doi: 10.1016/j.mri.2020.08.017. Epub 2020 Sep 2. Magn Reson Imaging. 2020. PMID: 32889090
Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis.
Galli A, Moretti S, Dule N, Di Cairano ES, Castagna M, Marciani P, Battaglia C, Bertuzzi F, Pastore I, Fiorina P, La Rosa S, Davalli A, Folli F, Perego C. Galli A, et al. Among authors: castagna m. Am J Physiol Endocrinol Metab. 2024 May 1. doi: 10.1152/ajpendo.00069.2024. Online ahead of print. Am J Physiol Endocrinol Metab. 2024. PMID: 38690938
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery.
Bufano A, Iraci Sareri G, Ciuoli C, Cantara S, Marzocchi C, Benenati N, Batzibal MS, Bombardieri A, Caprio S, Sannino I, Voglino C, Tirone A, Vuolo G, Dalmiglio C, Castagna MG. Bufano A, et al. Among authors: castagna mg. Obes Surg. 2024 Feb;34(2):449-455. doi: 10.1007/s11695-023-06972-x. Epub 2023 Dec 11. Obes Surg. 2024. PMID: 38072893
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value.
Citarella A, Besharat ZM, Trocchianesi S, Autilio TM, Verrienti A, Catanzaro G, Splendiani E, Spinello Z, Cantara S, Zavattari P, Loi E, Romei C, Ciampi R, Pezzullo L, Castagna MG, Angeloni A, Elisei R, Durante C, Po A, Ferretti E. Citarella A, et al. Among authors: castagna mg. Biomark Res. 2023 Sep 19;11(1):82. doi: 10.1186/s40364-023-00522-4. Biomark Res. 2023. PMID: 37726827 Free PMC article.
368 results